2014
DOI: 10.5999/aps.2014.41.6.620
|View full text |Cite
|
Sign up to set email alerts
|

Recent Developments in the Use of Intralesional Injections Keloid Treatment

Abstract: Keloid scars are often considered aesthetically unattractive and frustrating problems that occur following injuries. They cause functional and cosmetic deformities, displeasure, itching, pain, and psychological stress and possibly affect joint movement. The combination of these factors ultimately results in a compromised quality of life and diminished functional performance. Various methods have been implemented to improve keloid scars using both surgical and non-surgical approaches. However, it has proven to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
81
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 102 publications
(83 citation statements)
references
References 72 publications
(153 reference statements)
2
81
0
Order By: Relevance
“…30 It also exhibits antibacterial and antiviral activities. Bleomycin can be used as intralesional injections.…”
Section: Bleomycinmentioning
confidence: 99%
“…30 It also exhibits antibacterial and antiviral activities. Bleomycin can be used as intralesional injections.…”
Section: Bleomycinmentioning
confidence: 99%
“…As in any injection in connective tissue, the patient may experience pain at the injection site and recurrence in variable rates (less than 50% of cases). It is important to mention that other therapeutic options such as interferon, bleomycin, 5-FU and steroids have shown higher incidence of adverse effects [21,22] (Table 1).…”
Section: Verapamil As a Therapeutic Alternativementioning
confidence: 99%
“…They may be a reasonable and safe alternative to corticosteroid injection for the treatment of hypertrophic scars and keloids. 15,25 The literature on this subject is relatively sparse and many studies are limited by small patient cohorts. Given these limitations within the literature, it has been difficult to make evidence-based decisions weighing the potential side effects against the benefits of treatment with a calcium channel blocker.…”
mentioning
confidence: 99%